NFKB1 and colitis: Given that the previous studies showed that 2-Cl-IB-MECA could exert its anti-inflammatory effects by blocking NF-κB activation in some inflammatory diseases in vitro and in vivo, we investigated this signaling pathway in the DSS-colitis murine model to confirm its role in vivo.